Free provider profile
GREGORY BUNT, M.D.
NPI 1063420057
Individual
Psychiatry & Neurology, Addiction Medicine
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2009-11-18.
54 WEST 40TH STREET, NEW YORK, NY, 10018
212-354-6000
Single practice location
Enumerated 2006-08-04
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 16 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
244
Medicare patients
57
Part D drug cost
$61,734
Brand-name share
11.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ketoconazole (Ketoconazole) | 18 | $708 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 16 | $275 |
| Alprazolam (Alprazolam) | 12 | $35 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202464 sessions · 12 patients · $54,792
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.